Partnering to Achieve Epidemic Control in Tanzania

Get Acrobat Reader PDF version

Date: 08/03/2016 Description: PEPFAR Tanzania logo - State Dept Image

 

The United States is proud to support Tanzania’s leadership in the global HIV/AIDS response. PEPFAR investments support technical assistance and direct delivery of HIV care, treatment, and prevention services, in partnership with the Government of Tanzania; the Global Fund to Fight AIDS, Tuberculosis and Malaria; and other development partners. These efforts maximize the quality, coverage, and impact of the national HIV/AIDS response on the mainland and in Zanzibar. This work is aligned with national policies and the Government of Tanzania’s investments in health infrastructure and personnel.

Tanzania is participating in the Accelerating Children’s HIV/AIDS Treatment Initiative, a two-year effort that will enable 300,000 more children living with HIV/AIDS to receive life-saving antiretroviral treatment (ART); the Together for Girls Initiative, focused on eliminating sexual violence against children; and the Pink Ribbon Red Ribbon partnership, aimed at reducing deaths from cervical and breast cancer in sub-Saharan Africa. Additionally, the national government is taking steps to increase domestic funding for HIV/AIDS through the AIDS Trust Fund. To accelerate progress toward epidemic control, PEPFAR is realigning its programmatic portfolio to support interventions known to be most effective at treating and preventing HIV. Specific priorities include

§  Preventing mother-to-child transmission (PMTCT) and supporting Option B+

§  Targeting treatment, care, and support for key and vulnerable populations 

§  Strengthening HIV testing and counseling

§  Expanding voluntary medical male circumcision (VMMC) services

§  Strengthening national health systems 

 

HIV/AIDS in Tanzania

Number of people living with HIV (all ages), 20141

1,500,000

Deaths due to AIDS (all ages), 20141

46,000

Number of orphans due to AIDS (0-17), 20141

1,200,000

Estimated antiretroviral treatment coverage (adults ages 15+), 20142

44%

Estimated percentage of pregnant women living with HIV who receive antiretroviral medications for PMTCT, 20142

N/A


Saving Lives

In 2015, PEPFAR supported the following achievements in Tanzania:

  • Life-saving antiretroviral treatment for 638,000 people
  • VMMC for HIV prevention for 615,000 men
  • Testing and counseling for 6.2 million people, including 1.6 million pregnant women
  • Antiretroviral medications for 61,296 pregnant women living with HIV to reduce the risk of mother-to-child transmission

Get the most up-to-date data on program results, expenditures, and planned funding at Data.pepfar.net.

PEPFAR Planned Funding in Tanzania, 2004-2015 (USD in Millions)3

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

$74

$106

$130

$206

$313

$311

$356

$357

$290

$348

$375

$412


  1. UNAIDS. (2014). Tanzania: HIV and AIDS estimates. Retrieved November 3, 2015, from http://www.unaids.org/en/regionscountries/countries/unitedrepublicoftanzania
  2. UNAIDS. (2015). How AIDS changed everything. Geneva, Switzerland: Author.
  3. Data reflect information available on the PEPFAR Dashboards and PEPFAR.gov, which represent planned new bilateral funding initially approved in the PEPFAR Country Operational Plans/Regional Operational Plans (COPs/ROPs) each fiscal year. As additional funding may be approved and made available after the initial COPs/ROPs submission, or to PEPFAR-supported countries that are not required to submit an annual COP/ROP, data on the dashboards may not represent the final PEPFAR programmatic funding level in countries each fiscal year.
     
 


USA.gov U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA